Search Results - "INGUI, Manuela"

Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study by Oliva, Cristiano, Bergnolo, Paola, Inguì, Manuela, Bianco, Lavinia, Pochettino, Paolo, Cutin, Simona Chiadò, Boglione, Antonella, Dal Canton, Orietta, Garetto, Ferdinando, Comandone, Alessandro

“…Purpose This phase II study was designed in order to evaluate efficacy and safety of the combination of vinorelbine (VNB), fluorouracil (FU) and leucovorin…”
Get full text

Delay in diagnosis and treatment of soft tissue sarcomas (STS): Causes of late intervention and their role in prognosis—A prospective, multidisciplinary group study by Comandone, Alessandro, Berno, Elisa, Boglione, Antonella, Oliva, Cristiano, Ingui', Manuela, Linari, Alessandra, Giubellino, Elena, Gino, Giancarlo, Brach del Prever, Elena Maria, Faletti, Carlo, Piana, Raimondo, Turbiglio, Marco, Monasterolo, Gabriella, Pochettino, Paolo, Dal Canton, Orietta, Chiado' Cutin, Simona, Bergnolo, Paola

“…Abstract only 10055 Background: STS are 1% of malignant tumors in adults. Rarity, heterogeneity in presentation, low expertise in primary care physicians (PCP)…”
Get full text

Weekly Irinotecan Plus Protracted Venous Fluorouracil Infusion (WI-FI) in Advanced Colorectal Cancer: A Phase II Study by OLIVA, Cristiano, POCHETTINO, Paolo, COMANDONE, Alessandro, BERGNOLO, Paola, BOGLIONE, Antonella, CHIADO CUTIN, Simona, INGUI, Manuela, DAL CANTON, Orietta, GARETTO, Ferdinando, BISCARDI, Manuela, BERNO, Elisa

“…Background: Irinotecan (IRI) is a topoisomerase I inhibitor active as first- or second-line chemotherapy in advanced colorectal cancer (ACRC). Its combination…”
Get full text